Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-sta...
Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study
About this item
Full title
Author / Creator
Publisher
Belle Mead, NJ: EM Inc USA
Journal title
Language
English
Formats
Publication information
Publisher
Belle Mead, NJ: EM Inc USA
Subjects
More information
Scope and Contents
Contents
Abstract Background: Rupatadine is an oral active antihistamine and platelet-activating factor antagonist indicated for the management of allergic rhinitis and chronic urticaria in Europe. Objective: The purpose of this study was to describe the effect of the concomitant administration of azithromycin and rupatadine on the pharmacokinetics of rupat...
Alternative Titles
Full title
Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1033157094
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1033157094
Other Identifiers
ISSN
0149-2918
E-ISSN
1879-114X
DOI
10.1016/j.clinthera.2008.09.002
